DiaMedica Therapeutics Inc. Annual Income Tax Expense (Benefit) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
DiaMedica Therapeutics Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2018 to 2023.
  • DiaMedica Therapeutics Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $7K, unchanged year-over-year.
  • DiaMedica Therapeutics Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $43K, a 53.6% increase year-over-year.
  • DiaMedica Therapeutics Inc. annual Income Tax Expense (Benefit) for 2023 was $43K, a 53.6% increase from 2022.
  • DiaMedica Therapeutics Inc. annual Income Tax Expense (Benefit) for 2022 was $28K, unchanged from 2021.
  • DiaMedica Therapeutics Inc. annual Income Tax Expense (Benefit) for 2021 was $28K, a 3.7% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $43K +$15K +53.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $28K $0 0% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $28K +$1K +3.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 $27K -$4K -12.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $31K -$49K -61.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-10
2018 $80K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.